News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aerocrine: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (FeNO) Testing To Help Diagnose And Manage Asthma


4/2/2014 8:40:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AERO-B) today announced that NICE (National Institute for Health and Care Excellence) has published guidelines(http://www.nice.org.uk/newsroom/news/SimpleTestToHelpDiagnoseAndManageAsthma.jsp) recommending the use of Aerocrine’s NIOX MINO® and NIOX VERO® to help guide the diagnosis and management of asthma in both adults and children.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES